UK Trials World’s First Personalized mRNA Vaccine for Melanoma
Doctors have started trials of the world’s first personalized mRNA vaccine for melanoma. The world’s first personalized mRNA vaccine for melanoma has entered phase 3 trials. Developed to target tumor neoantigens.